featured
First-Line Immune Checkpoint Blockade vs Carboplatin-Based Chemotherapy for Metastatic Urothelial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of First-Line Immune Checkpoint Blockade Versus Carboplatin-Based Chemotherapy for Metastatic Urothelial Cancer
Eur Urol 2019 Jul 27;[EPub Ahead of Print], E Feld, J Harton, NJ Meropol, BJS Adamson, A Cohen, RB Parikh, MD Galsky, V Narayan, J Christodouleas, DJ Vaughn, RA Hubbard, R MamtaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.